Skip to content
Open access

Selective rolling circle amplification detection of site-specific DNA 5-hydroxymethylcytosine

Sep 2026 · Frontiers in Immunology · 0 citations · 31 references

Abstract

Site-specific 5-hydroxymethylcytosine (5hmC) has been identified as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. However, directly distinguishing trace levels of 5hmC from its highly abundant cytosine/5-methylcytosine (C/5mC) analogs remains a technical challenge. Herein, we present a 5hmC selective ligation-rolling circle amplification (5hmC-RCA) that enables the direct, high-specificity discrimination of 5hmC from C/5mC. The high specificity of 5hmC-RCA depends on the high selectivity of HiFi Taq DNA Ligase, which exhibits robust tolerance for mismatched 5hmC/A base pairs, thereby efficiently ligating the associated nicking site. While the mismatched 5mC/A or C/A pairs fail to be recognized by HiFi Taq DNA Ligase. As a proof of principle, the 5hmC-RCA assay was evaluated for its performance using Septin9 gene, which considered as key biomarkers in the prognosis and diagnosis of CRC, as the target, demonstrating a detection sensitivity of approximately 0.5%. Notably, the assay exhibited no cross-reactivity with unmodified target even at a high background concentration of 5,000 copies per reaction. By coupling HiFi Taq DNA Ligase-mediated high selective ligation with RCA, sensitive and selective quantification of site-specific 5hmC is achieved. Due to the simplicity of 5hmC-RCA, it also has potential for use in cfDNA originating from the tumor microenvironment and immune cells.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.